Share Price and Basic Stock Data
Last Updated: November 15, 2025, 1:55 pm
| PEG Ratio | 0.54 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ashok Leyland Ltd, a prominent player in the Indian automotive sector specializing in light commercial vehicles (LCVs) and heavy commercial vehicles (HCVs), reported a market capitalization of ₹82,293 Cr with a share price of ₹140. The company demonstrated strong revenue growth, with sales rising from ₹26,237 Cr in FY 2022 to ₹41,673 Cr in FY 2023, reflecting a robust recovery post-pandemic. The trailing twelve months (TTM) sales stood at ₹49,547 Cr, indicating a steady upward trajectory. Notably, the quarterly sales for Mar 2024 reached ₹13,542 Cr, showcasing the company’s ability to generate significant revenue. The sales trends indicate resilience, with Q2 FY 2024 sales at ₹11,429 Cr and Q3 FY 2024 at ₹11,093 Cr, highlighting stable demand across its vehicle segments. The company’s operational efficiency is further illustrated by a consistent increase in operating profit margin (OPM), which stood at 19% in FY 2024, up from 12% in FY 2023. This growth is indicative of Ashok Leyland’s effective cost management and market positioning strategies.
Profitability and Efficiency Metrics
Ashok Leyland’s profitability metrics reveal a significantly improved financial performance. The net profit for FY 2023 was reported at ₹1,359 Cr, which rose to ₹2,696 Cr in FY 2024, showcasing a commendable growth trajectory. The return on equity (ROE) stood at 28.8%, indicating effective utilization of shareholder funds to generate profits. The return on capital employed (ROCE) was reported at 14.3%, reflecting the company’s efficient capital management. Additionally, the interest coverage ratio (ICR) was recorded at 2.43x, signaling that the company can comfortably meet its interest obligations, which stood at ₹3,930 Cr for FY 2025. The cash conversion cycle (CCC) was a notable -21 days, underscoring Ashok Leyland’s efficient management of working capital. However, the company’s net profit margin of 6.90% in FY 2025 indicates a potential area for improvement compared to the sector average, which typically ranges higher, suggesting that while Ashok Leyland is profitable, there may be room for enhancing margins through strategic operational efficiencies.
Balance Sheet Strength and Financial Ratios
Ashok Leyland’s balance sheet exhibits a mix of strength and challenges. The company reported total borrowings of ₹49,962 Cr, which, against reserves of ₹11,938 Cr, presents a relatively high leverage situation with a total debt-to-equity ratio of 4.06x. This suggests a reliance on debt financing, which can pose risks in a rising interest rate environment. However, the company maintained a current ratio of 1.29, indicating adequate short-term liquidity to cover its obligations. The book value per share increased to ₹41.66 in FY 2025, which is a positive indicator of the company’s net asset value. Moreover, the asset turnover ratio stood at 0.64, showcasing effective use of assets in generating revenue. While the operating profit margin improved significantly, the overall efficiency ratios indicate that Ashok Leyland has room to enhance its operational efficiency to better leverage its asset base. These financial metrics provide insight into the company’s operational health and guide investor assessments.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ashok Leyland reflects a stable structure with significant promoter ownership at 51.52%. This strong promoter holding can instill confidence among investors regarding the management’s commitment to the company’s long-term vision. Foreign institutional investors (FIIs) held 24.02% of the shares as of Mar 2025, indicating robust foreign interest in the company, while domestic institutional investors (DIIs) accounted for 13.61%. The public shareholding stood at 10.77%, which suggests a healthy distribution of shares among various stakeholders. Over the reporting periods, FIIs’ stake increased from 15.29% in Dec 2022 to 24.02% in Mar 2025, signaling growing investor confidence in Ashok Leyland’s prospects. However, the decline in DII holdings from 21.16% in Dec 2022 to 13.61% in Mar 2025 may raise questions about domestic investor sentiment. The total number of shareholders increased to 14,12,491, indicating growing retail investor interest, which is a positive sign for the company’s market perception.
Outlook, Risks, and Final Insight
Ashok Leyland’s outlook appears promising, driven by strong revenue growth and improving profitability metrics. However, the significant reliance on debt financing poses a risk, especially with rising interest rates, which could impact profit margins and cash flow. The company’s ability to enhance operational efficiencies and manage costs will be critical in maintaining its competitive edge. Additionally, fluctuations in raw material prices and changes in regulatory frameworks could impact profitability. As the automotive sector shifts towards electric vehicles, Ashok Leyland must strategically navigate this transition to remain relevant. The company’s strong promoter backing and increasing foreign investment suggest a solid foundation for future growth. In conclusion, while Ashok Leyland faces some challenges, its strong revenue performance and improving operational metrics provide a basis for optimism, contingent upon effective risk management and strategic planning in an evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ashok Leyland Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Force Motors Ltd | 23,256 Cr. | 17,650 | 22,000/6,125 | 28.4 | 2,302 | 0.23 % | 30.0 % | 20.8 % | 10.0 |
| SML ISUZU Ltd | 4,547 Cr. | 3,142 | 4,745/1,028 | 32.1 | 307 | 0.57 % | 27.1 % | 36.4 % | 10.0 |
| Olectra Greentech Ltd | 11,549 Cr. | 1,407 | 1,714/974 | 80.8 | 137 | 0.03 % | 20.5 % | 14.3 % | 4.00 |
| Tata Motors Ltd | 1,47,974 Cr. | 402 | 538/324 | 6.84 | 316 | 1.49 % | 20.0 % | 28.1 % | 2.00 |
| Ashok Leyland Ltd | 87,086 Cr. | 148 | 153/95.2 | 26.0 | 21.4 | 2.11 % | 14.3 % | 28.8 % | 1.00 |
| Industry Average | 54,882.40 Cr | 4,549.80 | 34.83 | 616.68 | 0.89% | 22.38% | 25.68% | 5.40 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,470 | 9,600 | 10,400 | 13,203 | 9,691 | 11,429 | 11,093 | 13,542 | 10,724 | 11,148 | 11,995 | 14,696 | 11,709 |
| Expenses | 7,701 | 8,580 | 9,055 | 11,245 | 8,183 | 9,559 | 9,131 | 10,975 | 8,856 | 9,108 | 9,659 | 11,705 | 9,535 |
| Operating Profit | 770 | 1,020 | 1,344 | 1,958 | 1,509 | 1,870 | 1,961 | 2,567 | 1,868 | 2,040 | 2,336 | 2,991 | 2,173 |
| OPM % | 9% | 11% | 13% | 15% | 16% | 16% | 18% | 19% | 17% | 18% | 19% | 20% | 19% |
| Other Income | 5 | 32 | 36 | 97 | 53 | -1 | 46 | 10 | 36 | 245 | 75 | 22 | 103 |
| Interest | 467 | 499 | 545 | 582 | 655 | 715 | 783 | 829 | 904 | 962 | 1,011 | 1,053 | 1,112 |
| Depreciation | 212 | 209 | 220 | 259 | 227 | 227 | 241 | 233 | 235 | 244 | 268 | 340 | 273 |
| Profit before tax | 96 | 344 | 615 | 1,214 | 679 | 927 | 984 | 1,516 | 765 | 1,078 | 1,132 | 1,621 | 891 |
| Tax % | 77% | 46% | 43% | 34% | 14% | 39% | 38% | 38% | 28% | 29% | 28% | 23% | 26% |
| Net Profit | 22 | 186 | 351 | 803 | 584 | 569 | 609 | 934 | 551 | 767 | 820 | 1,246 | 658 |
| EPS in Rs | 0.01 | 0.28 | 0.54 | 1.28 | 0.93 | 0.90 | 0.95 | 1.45 | 0.87 | 1.20 | 1.30 | 1.92 | 1.04 |
Last Updated: August 20, 2025, 1:30 pm
Below is a detailed analysis of the quarterly data for Ashok Leyland Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11,709.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,696.00 Cr. (Mar 2025) to 11,709.00 Cr., marking a decrease of 2,987.00 Cr..
- For Expenses, as of Jun 2025, the value is 9,535.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11,705.00 Cr. (Mar 2025) to 9,535.00 Cr., marking a decrease of 2,170.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 2,173.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,991.00 Cr. (Mar 2025) to 2,173.00 Cr., marking a decrease of 818.00 Cr..
- For OPM %, as of Jun 2025, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 19.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 103.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 103.00 Cr., marking an increase of 81.00 Cr..
- For Interest, as of Jun 2025, the value is 1,112.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,053.00 Cr. (Mar 2025) to 1,112.00 Cr., marking an increase of 59.00 Cr..
- For Depreciation, as of Jun 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 340.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 67.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 891.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,621.00 Cr. (Mar 2025) to 891.00 Cr., marking a decrease of 730.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 26.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 658.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,246.00 Cr. (Mar 2025) to 658.00 Cr., marking a decrease of 588.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.04. The value appears to be declining and may need further review. It has decreased from 1.92 (Mar 2025) to 1.04, marking a decrease of 0.88.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11,859 | 15,708 | 21,260 | 22,871 | 29,636 | 33,197 | 21,951 | 19,454 | 26,237 | 41,673 | 45,791 | 42,333 | 50,976 |
| Expenses | 11,437 | 14,191 | 18,281 | 19,826 | 25,387 | 28,287 | 18,718 | 16,992 | 23,472 | 36,580 | 37,848 | 39,327 | 41,035 |
| Operating Profit | 422 | 1,517 | 2,979 | 3,045 | 4,248 | 4,910 | 3,233 | 2,462 | 2,765 | 5,093 | 7,943 | 3,006 | 9,942 |
| OPM % | 4% | 10% | 14% | 13% | 14% | 15% | 15% | 13% | 11% | 12% | 17% | 7% | 20% |
| Other Income | 613 | -106 | -321 | 406 | 190 | 139 | 57 | 207 | -230 | 166 | 73 | 6,607 | 304 |
| Interest | 805 | 872 | 925 | 1,049 | 1,227 | 1,502 | 1,802 | 1,901 | 1,869 | 2,094 | 2,982 | 3,930 | 4,328 |
| Depreciation | 530 | 580 | 524 | 573 | 646 | 676 | 750 | 836 | 866 | 900 | 927 | 1,087 | 1,149 |
| Profit before tax | -300 | -42 | 1,209 | 1,829 | 2,565 | 2,872 | 739 | -67 | -200 | 2,265 | 4,106 | 4,596 | 4,768 |
| Tax % | -23% | 415% | 41% | 11% | 29% | 24% | 38% | 4% | 43% | 40% | 34% | 26% | |
| Net Profit | -222 | -205 | 712 | 1,633 | 1,814 | 2,195 | 460 | -70 | -285 | 1,359 | 2,696 | 3,383 | 3,543 |
| EPS in Rs | -0.31 | 0.24 | 1.20 | 2.79 | 3.01 | 3.54 | 0.57 | -0.28 | -0.61 | 2.11 | 4.23 | 5.29 | 5.55 |
| Dividend Payout % | 0% | 96% | 40% | 28% | 40% | 44% | 44% | -107% | -82% | 62% | 59% | 59% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.66% | 447.32% | 129.35% | 11.08% | 21.00% | -79.04% | -115.22% | -307.14% | 576.84% | 98.38% | 25.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | 439.66% | -317.96% | -118.27% | 9.92% | -100.05% | -36.17% | -191.93% | 883.98% | -478.46% | -72.90% |
Ashok Leyland Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 17% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 54% |
| 3 Years: | 284% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 30% |
| 3 Years: | 16% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 15% |
| 3 Years: | 25% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 11:45 pm
Balance Sheet
Last Updated: July 25, 2025, 3:34 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 266 | 285 | 285 | 285 | 293 | 294 | 294 | 294 | 294 | 294 | 294 | 294 |
| Reserves | 3,723 | 4,227 | 4,979 | 6,108 | 7,128 | 8,452 | 7,495 | 7,568 | 7,010 | 8,258 | 8,711 | 11,938 |
| Borrowings | 8,500 | 9,070 | 11,054 | 13,168 | 15,791 | 19,168 | 22,417 | 24,077 | 24,145 | 31,161 | 40,802 | 49,962 |
| Other Liabilities | 5,035 | 6,011 | 5,806 | 7,048 | 10,171 | 11,212 | 7,924 | 10,119 | 12,125 | 14,984 | 17,788 | 19,352 |
| Total Liabilities | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 |
| Fixed Assets | 7,573 | 6,529 | 5,890 | 6,591 | 6,596 | 6,695 | 8,031 | 8,484 | 7,895 | 8,146 | 8,157 | 8,837 |
| CWIP | 297 | 216 | 87 | 244 | 439 | 678 | 574 | 336 | 240 | 268 | 415 | 577 |
| Investments | 1,165 | 1,499 | 1,031 | 1,933 | 4,383 | 1,492 | 960 | 1,096 | 2,652 | 4,852 | 2,329 | 6,610 |
| Other Assets | 8,491 | 11,348 | 15,115 | 17,841 | 21,965 | 30,261 | 28,565 | 32,143 | 32,787 | 41,430 | 56,695 | 65,523 |
| Total Assets | 17,524 | 19,592 | 22,123 | 26,609 | 33,383 | 39,126 | 38,130 | 42,058 | 43,574 | 54,697 | 67,595 | 81,546 |
Below is a detailed analysis of the balance sheet data for Ashok Leyland Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 294.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 294.00 Cr..
- For Reserves, as of Mar 2025, the value is 11,938.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,711.00 Cr. (Mar 2024) to 11,938.00 Cr., marking an increase of 3,227.00 Cr..
- For Borrowings, as of Mar 2025, the value is 49,962.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 40,802.00 Cr. (Mar 2024) to 49,962.00 Cr., marking an increase of 9,160.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 19,352.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,788.00 Cr. (Mar 2024) to 19,352.00 Cr., marking an increase of 1,564.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 81,546.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67,595.00 Cr. (Mar 2024) to 81,546.00 Cr., marking an increase of 13,951.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 8,837.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,157.00 Cr. (Mar 2024) to 8,837.00 Cr., marking an increase of 680.00 Cr..
- For CWIP, as of Mar 2025, the value is 577.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Mar 2024) to 577.00 Cr., marking an increase of 162.00 Cr..
- For Investments, as of Mar 2025, the value is 6,610.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,329.00 Cr. (Mar 2024) to 6,610.00 Cr., marking an increase of 4,281.00 Cr..
- For Other Assets, as of Mar 2025, the value is 65,523.00 Cr.. The value appears strong and on an upward trend. It has increased from 56,695.00 Cr. (Mar 2024) to 65,523.00 Cr., marking an increase of 8,828.00 Cr..
- For Total Assets, as of Mar 2025, the value is 81,546.00 Cr.. The value appears strong and on an upward trend. It has increased from 67,595.00 Cr. (Mar 2024) to 81,546.00 Cr., marking an increase of 13,951.00 Cr..
However, the Borrowings (49,962.00 Cr.) are higher than the Reserves (11,938.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 414.00 | -8.00 | -9.00 | -10.00 | -11.00 | -15.00 | -19.00 | -22.00 | -22.00 | -26.00 | -33.00 | -46.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 31 | 25 | 20 | 14 | 30 | 25 | 57 | 45 | 37 | 35 | 29 |
| Inventory Days | 69 | 58 | 50 | 73 | 42 | 52 | 42 | 76 | 53 | 44 | 50 | 49 |
| Days Payable | 116 | 108 | 71 | 85 | 96 | 88 | 90 | 162 | 150 | 96 | 85 | 99 |
| Cash Conversion Cycle | -5 | -19 | 5 | 8 | -39 | -6 | -22 | -30 | -52 | -16 | -0 | -21 |
| Working Capital Days | -45 | -41 | -23 | -21 | -54 | -13 | -31 | -44 | -52 | -34 | -50 | -37 |
| ROCE % | 8% | 17% | 15% | 17% | 16% | 9% | 5% | 6% | 11% | 15% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Balanced Advantage Fund | 18,247,500 | 1.17 | 320.97 | 18,247,500 | 2025-04-22 17:25:42 | 0% |
| Kotak Equity Opportunities Fund - Regular Plan | 16,500,000 | 1.58 | 290.24 | 16,500,000 | 2025-04-22 17:25:42 | 0% |
| Canara Robeco Emerging Equities | 15,619,515 | 1.38 | 274.75 | 15,619,515 | 2025-04-22 17:25:42 | 0% |
| Nippon India Growth Fund | 12,500,000 | 0.9 | 219.88 | 12,500,000 | 2025-04-22 17:25:42 | 0% |
| Kotak Flexicap Fund - Regular Plan | 11,500,000 | 0.46 | 202.29 | 11,500,000 | 2025-04-22 14:53:35 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 11,340,000 | 0.55 | 199.47 | 11,340,000 | 2025-04-22 17:25:42 | 0% |
| SBI Large & Midcap Fund | 11,000,000 | 0.97 | 193.49 | 11,000,000 | 2025-04-22 17:25:42 | 0% |
| SBI Contra Fund | 10,441,072 | 0.78 | 183.66 | 10,441,072 | 2025-04-22 17:25:42 | 0% |
| UTI Mid Cap Fund | 8,511,102 | 1.49 | 149.71 | 8,511,102 | 2025-04-22 17:25:42 | 0% |
| ICICI Prudential Balanced Advantage Fund | 7,614,666 | 0.25 | 133.94 | 7,614,666 | 2025-04-22 17:25:42 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| Diluted EPS (Rs.) | 10.56 | 8.45 | 4.22 | -1.22 | -0.56 |
| Cash EPS (Rs.) | 15.11 | 12.29 | 7.67 | 1.95 | 2.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 41.66 | 40.23 | 36.78 | 29.26 | 31.10 |
| Revenue From Operations / Share (Rs.) | 165.28 | 155.95 | 141.93 | 89.38 | 66.27 |
| PBDIT / Share (Rs.) | 32.58 | 27.53 | 17.72 | 9.72 | 8.84 |
| PBIT / Share (Rs.) | 28.88 | 24.37 | 14.66 | 6.77 | 5.99 |
| PBT / Share (Rs.) | 15.54 | 13.93 | 7.69 | -0.70 | -0.22 |
| Net Profit / Share (Rs.) | 11.41 | 9.13 | 4.60 | -0.99 | -0.23 |
| NP After MI And SOA / Share (Rs.) | 10.58 | 8.46 | 4.23 | -1.22 | -0.56 |
| PBDIT Margin (%) | 19.70 | 17.65 | 12.48 | 10.87 | 13.33 |
| PBIT Margin (%) | 17.47 | 15.62 | 10.32 | 7.56 | 9.03 |
| PBT Margin (%) | 9.40 | 8.93 | 5.41 | -0.78 | -0.34 |
| Net Profit Margin (%) | 6.90 | 5.85 | 3.24 | -1.11 | -0.35 |
| NP After MI And SOA Margin (%) | 6.40 | 5.42 | 2.97 | -1.36 | -0.84 |
| Return on Networth / Equity (%) | 25.39 | 27.58 | 14.50 | -4.90 | -2.10 |
| Return on Capital Employeed (%) | 15.37 | 17.46 | 13.33 | 7.94 | 6.80 |
| Return On Assets (%) | 3.80 | 3.67 | 2.26 | -0.82 | -0.39 |
| Long Term Debt / Equity (X) | 2.97 | 2.96 | 2.28 | 2.09 | 1.98 |
| Total Debt / Equity (X) | 4.06 | 4.51 | 3.61 | 3.28 | 2.31 |
| Asset Turnover Ratio (%) | 0.64 | 0.74 | 0.84 | 0.69 | 0.54 |
| Current Ratio (X) | 1.29 | 1.09 | 1.08 | 0.99 | 0.98 |
| Quick Ratio (X) | 1.14 | 0.94 | 0.92 | 0.86 | 0.82 |
| Inventory Turnover Ratio (X) | 12.14 | 7.58 | 9.45 | 6.96 | 6.04 |
| Dividend Payout Ratio (NP) (%) | 18.90 | 89.26 | 23.65 | -49.11 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 14.00 | 64.99 | 13.71 | 34.71 | 0.00 |
| Earning Retention Ratio (%) | 81.10 | 10.74 | 76.35 | 149.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 86.00 | 35.01 | 86.29 | 65.29 | 0.00 |
| Interest Coverage Ratio (X) | 2.43 | 2.71 | 2.49 | 1.53 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.85 | 1.93 | 1.62 | 1.02 | 0.92 |
| Enterprise Value (Cr.) | 106013.76 | 86549.03 | 71834.36 | 57544.92 | 50957.36 |
| EV / Net Operating Revenue (X) | 2.18 | 1.89 | 1.72 | 2.19 | 2.62 |
| EV / EBITDA (X) | 11.08 | 10.71 | 13.80 | 20.18 | 19.65 |
| MarketCap / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| Retention Ratios (%) | 81.09 | 10.73 | 76.34 | 149.11 | 0.00 |
| Price / BV (X) | 4.90 | 5.58 | 4.78 | 4.71 | 4.24 |
| Price / Net Operating Revenue (X) | 1.24 | 1.10 | 0.98 | 1.31 | 1.71 |
| EarningsYield | 0.05 | 0.04 | 0.03 | -0.01 | 0.00 |
After reviewing the key financial ratios for Ashok Leyland Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.56. This value is within the healthy range. It has increased from 8.45 (Mar 24) to 10.56, marking an increase of 2.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.11. This value is within the healthy range. It has increased from 12.29 (Mar 24) to 15.11, marking an increase of 2.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 41.66. It has increased from 40.23 (Mar 24) to 41.66, marking an increase of 1.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.28. It has increased from 155.95 (Mar 24) to 165.28, marking an increase of 9.33.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.58. This value is within the healthy range. It has increased from 27.53 (Mar 24) to 32.58, marking an increase of 5.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 28.88. This value is within the healthy range. It has increased from 24.37 (Mar 24) to 28.88, marking an increase of 4.51.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.54. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 15.54, marking an increase of 1.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 11.41, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.58. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 10.58, marking an increase of 2.12.
- For PBDIT Margin (%), as of Mar 25, the value is 19.70. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 19.70, marking an increase of 2.05.
- For PBIT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 15.62 (Mar 24) to 17.47, marking an increase of 1.85.
- For PBT Margin (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 10. It has increased from 8.93 (Mar 24) to 9.40, marking an increase of 0.47.
- For Net Profit Margin (%), as of Mar 25, the value is 6.90. This value is within the healthy range. It has increased from 5.85 (Mar 24) to 6.90, marking an increase of 1.05.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.40. This value is below the healthy minimum of 8. It has increased from 5.42 (Mar 24) to 6.40, marking an increase of 0.98.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.39. This value is within the healthy range. It has decreased from 27.58 (Mar 24) to 25.39, marking a decrease of 2.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.37. This value is within the healthy range. It has decreased from 17.46 (Mar 24) to 15.37, marking a decrease of 2.09.
- For Return On Assets (%), as of Mar 25, the value is 3.80. This value is below the healthy minimum of 5. It has increased from 3.67 (Mar 24) to 3.80, marking an increase of 0.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 2.97. This value exceeds the healthy maximum of 1. It has increased from 2.96 (Mar 24) to 2.97, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 4.06. This value exceeds the healthy maximum of 1. It has decreased from 4.51 (Mar 24) to 4.06, marking a decrease of 0.45.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.74 (Mar 24) to 0.64, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.29. This value is below the healthy minimum of 1.5. It has increased from 1.09 (Mar 24) to 1.29, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.94 (Mar 24) to 1.14, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 8. It has increased from 7.58 (Mar 24) to 12.14, marking an increase of 4.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.90. This value is below the healthy minimum of 20. It has decreased from 89.26 (Mar 24) to 18.90, marking a decrease of 70.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.00. This value is below the healthy minimum of 20. It has decreased from 64.99 (Mar 24) to 14.00, marking a decrease of 50.99.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.10. This value exceeds the healthy maximum of 70. It has increased from 10.74 (Mar 24) to 81.10, marking an increase of 70.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.00. This value exceeds the healthy maximum of 70. It has increased from 35.01 (Mar 24) to 86.00, marking an increase of 50.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 3. It has decreased from 2.71 (Mar 24) to 2.43, marking a decrease of 0.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 3. It has decreased from 1.93 (Mar 24) to 1.85, marking a decrease of 0.08.
- For Enterprise Value (Cr.), as of Mar 25, the value is 106,013.76. It has increased from 86,549.03 (Mar 24) to 106,013.76, marking an increase of 19,464.73.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.18, marking an increase of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 10.71 (Mar 24) to 11.08, marking an increase of 0.37.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For Retention Ratios (%), as of Mar 25, the value is 81.09. This value exceeds the healthy maximum of 70. It has increased from 10.73 (Mar 24) to 81.09, marking an increase of 70.36.
- For Price / BV (X), as of Mar 25, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.58 (Mar 24) to 4.90, marking a decrease of 0.68.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.24. This value is within the healthy range. It has increased from 1.10 (Mar 24) to 1.24, marking an increase of 0.14.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ashok Leyland Ltd:
- Net Profit Margin: 6.9%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.37% (Industry Average ROCE: 22.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.39% (Industry Average ROE: 25.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.14
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26 (Industry average Stock P/E: 34.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 4.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.9%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto - LCVs/HCVs | No.1, Sardar Patel Road, Guindy, Chennai (Madras) Tamil Nadu 600032 | reachus@ashokleyland.com http://www.ashokleyland.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dheeraj G Hinduja | Executive Chairman |
| Mr. Shenu Agarwal | Managing Director & CEO |
| Mr. Shom Ashok Hinduja | Director |
| Ms. Sanjay K Asher | Director |
| Mr. Manisha Girotra | Director |
| Mr. Gopal Mahadevan | Director |
| Mr. Jose Maria Alapont | Director |
| Mr. Saugata Gupta | Director |
| Dr. C Bhaktavatsala Rao | Director |
| Dr. V Sumantran | Director |
| Mr. Thomas Dauner | Director |
| Mr. Sven Christoph Ennerst | Director |
FAQ
What is the intrinsic value of Ashok Leyland Ltd?
Ashok Leyland Ltd's intrinsic value (as of 15 November 2025) is 130.90 which is 11.55% lower the current market price of 148.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 87,086 Cr. market cap, FY2025-2026 high/low of 153/95.2, reserves of ₹11,938 Cr, and liabilities of 81,546 Cr.
What is the Market Cap of Ashok Leyland Ltd?
The Market Cap of Ashok Leyland Ltd is 87,086 Cr..
What is the current Stock Price of Ashok Leyland Ltd as on 15 November 2025?
The current stock price of Ashok Leyland Ltd as on 15 November 2025 is 148.
What is the High / Low of Ashok Leyland Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ashok Leyland Ltd stocks is 153/95.2.
What is the Stock P/E of Ashok Leyland Ltd?
The Stock P/E of Ashok Leyland Ltd is 26.0.
What is the Book Value of Ashok Leyland Ltd?
The Book Value of Ashok Leyland Ltd is 21.4.
What is the Dividend Yield of Ashok Leyland Ltd?
The Dividend Yield of Ashok Leyland Ltd is 2.11 %.
What is the ROCE of Ashok Leyland Ltd?
The ROCE of Ashok Leyland Ltd is 14.3 %.
What is the ROE of Ashok Leyland Ltd?
The ROE of Ashok Leyland Ltd is 28.8 %.
What is the Face Value of Ashok Leyland Ltd?
The Face Value of Ashok Leyland Ltd is 1.00.